Ads
related to: IRIX
Search results
IRIDEX Corp. (IRIX) Shares Up Despite Recent Market Volatility – News Heater
NewsHeater· 1 day agoThe stock of IRIDEX Corp. (NASDAQ: IRIX) has increased by 17.53 when compared to last closing price of 2.51.Despite this, the company has seen a gain of 22.92% in its stock ...
Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 3 days agoIRIDEX (IRIX) delivered earnings and revenue surprises of -260% and 16.39%, respectively, for the...
IRIDEX Corporation (NASDAQ:IRIX) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoIRIDEX Corporation (NASDAQ:IRIX) Q4 2023 Earnings Call Transcript March 26, 2024 IRIDEX Corporation...
IRIDEX (NASDAQ:IRIX) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 3 days agoStockNews.com started coverage on shares of IRIDEX (NASDAQ:IRIX – Free Report) in a research note released on Monday morning. The brokerage issued a hold rating on the medical ...
Earnings call: IRIDEX reports Q4 decline but remains optimistic on growth By Investing.com
Investing.com· 2 days agoIRIDEX Corporation (IRIX) has disclosed its financial outcomes for the fourth quarter of 2023,...
Iridex: Q4 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 3 days agoMOUNTAIN VIEW, Calif. (AP) — MOUNTAIN VIEW, Calif. (AP) — Iridex Corp. (IRIX) on Tuesday reported a loss of $3 million in its fourth quarter. The Mountain View, California-based ...
12 Health Care Stocks Moving In Tuesday's After-Market Session - Akili (NASDAQ:AKLI), Apollomics...
Benzinga· 3 days agoThe market value of their outstanding shares is at $5.8 million. BioSig Technologies BSGM shares increased by 6.38% to $0.5. The market value of their outstanding shares is at $4.6 million.
Earnings Scheduled For March 26, 2024 - ATA Creativity Glb (NASDAQ:AACG), Acumen Pharmaceuticals...
Benzinga· 3 days agoCompanies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.